<ѻý>Workplace Wellness Program Triumphs for Hypertensionѻý> Two-thirds meet blood pressure target after 2 years Mar 04, 2020
<ѻý>Wearable Sensor Predicts Worsening Heart Failureѻý> Device flagged readmission risk nearly a week ahead in observational study Feb 26, 2020
<ѻý>SAVR Dominates in Younger Patients, but TAVR's Share Is Growing Fastѻý> Trends observed for those with or without congenital heart disease Jan 28, 2020
<ѻý>Ozempic OK'd for CV Prevention; LDL Drug Pricing; Lyme Disease Heart Txѻý> Recent developments of interest in cardiovascular medicine Jan 21, 2020
<ѻý>Bad News on Anti-HER2 Heart Effectsѻý> Exercise, however, may help improve cardio fitness in breast cancer survivors Jan 15, 2020
<ѻý>ARNI for Heart Failure: Earlier Is Betterѻý> "Optimal time" to give Entresto to hospitalized patients is "now" Dec 13, 2019
<ѻý>Entresto Holds Up in the Real World ... But Not for Everyoneѻý> Drug not better than ACE inhibitor, ARB for black patients? Dec 12, 2019
<ѻý>Decompensated HF: Managing Beta-Blockers, Cramping, Dischargeѻý> Michelle Kittleson, MD, PhD, shares her pearls in this podcast Dec 06, 2019 podcast
<ѻý>Gout Crystals in the Heart May Be the Link to HFѻý> Case suggests root of myocarditis with heart failure Dec 02, 2019
<ѻý>Oversupply of Congenital Heart Surgery Programs Slammedѻý> Researchers call for fewer hospitals in an organized, regionalized system Nov 18, 2019
<ѻý>Entresto Data Support Wider Reach of 'Fifth Pillar' HF Drugѻý> Benefits observed beyond HF patients with reduced EF Nov 17, 2019
<ѻý>Xarelto Harm for TAVR Patients Still Unexplainedѻý> GALILEO showed worse outcomes but less subclinical leaflet thrombosis Nov 16, 2019
<ѻý>HF Benefit of Dapagliflozin Affirmed in Non-Diabeticsѻý> Fewer CV events for heart failure with reduced ejection fraction Nov 16, 2019
<ѻý>Entresto Approved for Childrenѻý> Symptomatic HF population as young as 1 year given the green light Oct 03, 2019
<ѻý>TAVR at 5 Years: Paravalvular Regurgitation is Keyѻý> "No matter what you're using, you have to decrease PVR" Sep 29, 2019
<ѻý>MitraClip for Functional MR: 'It's Never Too Late'ѻý> Benefit grows versus meds over time and not hurt by delay in COAPT trial Sep 29, 2019
<ѻý>Mitral Valve Procedure Learning Curve Raises Access Questionѻý> And guess which procedures are next for public outcome reporting... Sep 27, 2019
<ѻý>Novel TAVR Valves: Mixed Results in First Head-to-Head Trialsѻý> With one a clear loser, another noninferior to existing devices, will operators want to climb the learning curve? Sep 27, 2019
<ѻý>Post-AVR Leaflet Thrombosis Often Vanishes Sans Treatmentѻý> Even so, PARTNER 3 substudy found more clinical events with leaflet thickening Sep 27, 2019
<ѻý>Could Sapien Valve Weather 25 Years With Little Wear?ѻý> A billion beats in bench testing say yes Sep 26, 2019
<ѻý>Dapagliflozin: More Good News in HFѻý> SGLT-2 inhibitor advantage in DAPA-HF extended across T2D status, ARNI use Sep 19, 2019
<ѻý>Translational Research: Diet Affects the Heart in Multiple Waysѻý> Inflammation, circadian rhythm, and beyond Sep 16, 2019
<ѻý>Shared Decision-Making: Cardiologists Moving Through the Stages of Griefѻý> Rules from CMS for ICDs, LAA closure feels arbitrary, some say Sep 16, 2019
<ѻý>Patiromer Helps CKD Patients Stay on Spironolactoneѻý> Now the question is: Can outcomes be improved? Sep 15, 2019
<ѻý>Study: LVAD Surgical Technique Can be Further Refinedѻý> Left ventricular assist device outflow cannula angulation, anastomosis size may be important Sep 15, 2019
<ѻý>Debate: Is LVEF Really that Important in Heart Failure?ѻý> Benefit of identifying preserved, reduced, mid-range, supranormal EF under question Sep 14, 2019
<ѻý>Post-MI Survival Better With ICD for Some, Troubled Trial Suggestsѻý> Potential benefit in STEMI survivors with severe LV dysfunction, other risk factors soon after PCI Sep 04, 2019
<ѻý>MITRA-FR Inches in Line With COAPT at 2 Years Despite Contradictory Findingsѻý> More evidence that the two trials are more concordant than previously thought Sep 02, 2019
<ѻý>Dapagliflozin Benefits HFrEF Outcomes, Even Without Diabetesѻý> DAPA-HF trial affirms similar benefit to diabetes drug regardless of type 2 diabetes status Sep 01, 2019 video
<ѻý>Entresto Signals Expansion Into 'Gray Zone' of HFpEFѻý> PARAGON-HF may have missed overall, but HF docs see reason for hope Sep 01, 2019
<ѻý>STICH: CABG Survival Benefit Doesn't Hinge on Myocardial Viabilityѻý> Is viability testing now unnecessary for CAD patients with low LVEF? Aug 21, 2019
<ѻý>There Is Such Thing as a Too-High LVEFѻý> Study suggests sweet spot and proposes fourth left ejection phenotype Aug 07, 2019
<ѻý>ATTR Cardiomyopathy: 'Red Flags' for Screeningѻý> Consensus group highlights eight things to look for Jul 11, 2019
<ѻý>Entresto Out-of-Pocket Costs Out of Control?ѻý> Study highlights one reason for "sluggish" uptake Jul 10, 2019
<ѻý>Carpal Tunnel Syndrome: 'Red Flag' for Subsequent ATTR, Heart Failureѻý> Goal is to catch cardiac amyloidosis early, clinicians say Jul 01, 2019
<ѻý>Another Tricuspid Repair System Shows Promiseѻý> Device is designed for individual leaflet capture Jun 17, 2019
<ѻý>Low-Risk TAVR: Listen to the Echo Parametersѻý> Smaller annuli may benefit more from transcatheter valves Jun 17, 2019
<ѻý>Makeover for TAVR Valves: Lower Profiles, Better Sealingѻý> Design features suggest several possibilities for improvement over current devices Jun 14, 2019
<ѻý>TAVR in Low-Risk Patients: Meta-Analyses Have Their Sayѻý> Improved outcomes overall, but not without downsides Jun 14, 2019
<ѻý>Pricey Brain Protection Devices of Questionable Value in TAVRѻý> Can TAVR programs survive using filters, deflectors in every case? Jun 13, 2019